Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Gene Therapy

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Nano-radiosensitizers targeting tumor radioresistance: mechanisms, rational design, and clinical prospects.

Chemical communications (Cambridge, England)·2026

Same author

DNAzyme-Enhanced CRISPR/Cas12a Cascade Enables Isothermal, One-Pot RNA Diagnostics.

ACS applied materials & interfaces·2026

Same author

DHA/Fe<sup>2+</sup>-doped porphyrin COFs enable ROS-amplified multimodal tumor therapy.

Chemical communications (Cambridge, England)·2026

Same author

Framework Doping Enhances COF-DNA Nanoplatforms for Dual RNA Imaging and Phototherapy.

Analytical chemistry·2026

Same author

A dual-strike strategy against glycolytic and mitochondrial metabolism for potentiated mild photothermal therapy.

Chemical communications (Cambridge, England)·2026

Same author

Dual-Cascade Activated DNAzyme Nanoreactor within a Zn-Based MOF for Mitochondrial Gene Regulation.

ACS applied materials & interfaces·2025

Search research articles

Related Experiment Video

Updated: Sep 3, 2025

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

Tumor microenvironment responsive nanocarriers for gene therapy.

Yanhua Li¹, Kun Tang¹, Xia Zhang¹

¹College of Chemistry, Chemical Engineering and Materials Science, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong, Institute of Molecular and Nano Science, Shandong Normal University, Jinan 250014, P. R. China. lina@sdnu.edu.cn.

Chemical Communications (Cambridge, England)

|July 26, 2022

Summary

This summary is machine-generated.

Stimuli-responsive nanocarriers are key non-viral vectors for gene therapy. This review explores their use in the tumor microenvironment to improve cancer gene therapy delivery and effectiveness.

More Related Videos

Predicting Gene Silencing Through the Spatiotemporal Control of siRNA Release from Photo-responsive Polymeric Nanocarriers

Predicting Gene Silencing Through the Spatiotemporal Control of siRNA Release from Photo-responsive Polymeric Nanocarriers

Published on: July 21, 2017

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

Related Experiment Videos

Last Updated: Sep 3, 2025

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

Predicting Gene Silencing Through the Spatiotemporal Control of siRNA Release from Photo-responsive Polymeric Nanocarriers

Predicting Gene Silencing Through the Spatiotemporal Control of siRNA Release from Photo-responsive Polymeric Nanocarriers

Published on: July 21, 2017

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

Area of Science:

Biomedical Engineering
Nanotechnology
Gene Therapy

Background:

Non-viral gene carriers are crucial for safe and effective gene therapy.
Stimuli-responsive nanocarriers offer targeted delivery advantages.
The tumor microenvironment presents unique challenges and opportunities for gene delivery.

Purpose of the Study:

To review stimuli-responsive nanocarriers for cancer gene therapy.
To discuss stimulus conditions relevant to the tumor microenvironment.
To inspire the development of advanced gene delivery systems.

Main Methods:

Literature review of stimuli-responsive nanocarriers.
Analysis of nanocarrier responses to tumor microenvironment stimuli.
Discussion of current applications and future directions in cancer gene therapy.

Main Results:

Various stimuli-responsive nanocarriers are effective for cancer gene therapy.
Specific stimuli (e.g., pH, temperature, enzymes) can trigger drug release in tumors.
Nanocarrier design can be optimized for enhanced tumor targeting and gene delivery.

Conclusions:

Stimuli-responsive nanocarriers show significant promise for cancer gene therapy.
Further research is needed to optimize nanocarrier design and clinical translation.
Targeted gene delivery using stimuli-responsive systems can improve therapeutic outcomes.